GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests

Medical Xpress

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well.

Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient population: people with type 2 diabetes who suffer from pulmonary fibrosis months or years after infection with SARS-CoV-2, the virus that causes COVID-19. ...

전문 보기

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Outbreak of diarrhea-causing parasite grows to more than 1,000 cases

Pregnant women may avoid child protection out of fear and mistrust

Why some people are more bothered by low-frequency sounds

Medical Xpress의 다른 기사

AI can't replace mental health therapists. But here's where it might make a difference

Softening aging ovaries could help extend fertility as women get older

Learning to identify new objects reshapes parts of the brain, research finds